42 OancaG.StareJ.MavriJ
Compared with standard glutathione (500 mg), LipoMicel at a lower dose (300 mg) increased iAUC and C max by ~2.49-fold and ~2.43-fold, respectively, and when dose-normalized (to a 300 mg equivalent), incremental systemic exposure and peak levels were up to ~4-fold higher, supporting greater absorption per unit dose. The findings indicate LipoMicel is a promising delivery method for oral glutathione, though the researchers added larger, long-term studies are still needed
Reported side effects range from mild (headache, nausea, injection-site reactions) to serious (allergic reactions, kidney strain, infection)
Additional Info: Approved by Ministry of Health
I'll add educational content later, once the core pages are ranking
The duration of results can vary, but many patients experience ongoing benefits with continued use under medical supervision